Drug Trial Radar · NCT00002160
A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain
Last checked: Nov 20, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
100
Actual
Start
Not stated
Primary completion
Not stated
Sponsor
- Lead sponsor
- NeurexIndustry
- Sponsor type
- Industry
- First posted
- Aug 31, 2001
Design
- Study type
- Interventional
- Phase
- Phase 2
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To determine the safety and efficacy of SNX-111 in controlling severe, chronic pain in cancer and AIDS patients.
Conditions
- HIV Infections
- Cancer
- Pain
Interventions
ZiconotideDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
44 sites in 1 country. Site status is shown where the registry gives one.
Ctr for Pain Management and Rehabilitation
Huntsville, Alabama
Gulf Coast Clinical Services
Mobile, Alabama
Northport Hosp
Northport, Alabama
Holt Krock Clinic
Fort Smith, Arkansas
Alta Bates Hosp
Berkeley, California
Pain Diagnosis and Treatment
Glendora, California
Univ of CA - San Diego
San Diego, California
Good Samaritan Hosp Ctr
San Jose, California
Connecticut Pain Care
Danbury, Connecticut
VA Med Ctr / Oncology Section
Washington D.C., District of Columbia
Univ of Miami School of Medicine
Miami, Florida
H Lee Moffit Cancer Ctr and Research Institute
Tampa, Florida
Emory Univ Hosp
Atlanta, Georgia
Cook County Hosp
Chicago, Illinois
Pain Control Ctr
Chicago, Illinois
Elkhardt Gen Hosp
Elkhardt, Indiana
Neurosurgical Associates
Terre Haute, Indiana
Univ of Iowa Hosp
Iowa City, Iowa
Univ of Kansas Med Ctr
Kansas City, Kansas
New Orleans Pharmaceutical Research
Kenner, Louisiana
Louisiana State Univ
Shreveport, Louisiana
Johns Hopkins Hosp
Baltimore, Maryland
Brigham and Women's Hosp
Boston, Massachusetts
Minneapolis Veterans Administration
Minneapolis, Minnesota
Univ of Missouri Med Ctr
Columbia, Missouri
The Pain Institute
Kansas City, Missouri
Cooper Hospital Early Intervention Program
Camden, New Jersey
Clinical Solutions
Princeton, New Jersey
Pain Management
New York, New York
Long Island Pain Management
Port Jefferson Station, New York
Univ of Rochester
Rochester, New York
Bowman Gray School of Medicine / Wake Forest Univ
Winston-Salem, North Carolina
Cleveland Clinic Foundation
Cleveland, Ohio
Lehigh Valley Hosp
Allentown, Pennsylvania
Pennsylvania State College of Medicine
Hershey, Pennsylvania
Thomas Jefferson Univ Hosp
Philadelphia, Pennsylvania
Methodist Hosp
Memphis, Tennessee
Univ of Tennessee
Memphis, Tennessee
Texas Tech Univ Health Science Ctr
Lubbock, Texas
Univ of Texas Health Sciences Ctr
San Antonio, Texas
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.